02:44:33 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Diagnos Inc (3)
Symbol ADK
Shares Issued 65,625,925
Close 2021-02-02 C$ 0.58
Market Cap C$ 38,063,037
Recent Sedar Documents

Diagnos to provide AI CARA tech to Enayah

2021-02-02 12:35 ET - News Release

Mr. Andre Larente reports

DIAGNOS ANNOUNCES FURTHER DEPLOYMENT OF ITS AI BASED CARA TECHNOLOGY IN SAUDI ARABIA

Diagnos Inc. will be deploying its artificial intelligence (AI) medical test for retina analysis at the Enayah mobile smart eye clinics operated by the Association of Charitable Health Society for Patient Care (Enayah), in collaboration with its Saudi business partner, Kanhoor Medical Co.

Enayah is one of the pioneers of humanitarian societies in the Kingdom of Saudi Arabia and is registered in the Ministry of Labor and Social Development. Its mission is to provide health care workers and lower-income patients with quality health care. As part of its program, known as combating blindness, Enayah will be deploying and operating a fleet of remote mobile smart eye clinics to increase accessibility to eye care for communities and patients with reduced mobility.

"For almost three years, Enayah has been using Diagnos's AI-based CARA platform successfully to screen thousands of diabetic patients for diabetic retinopathy with an early detection test. By using Diagnos's telemedicine solution, we have been able to identify patients needing care early so their vision can be saved. As part of our combating blindness program, we are extremely pleased to extend this service and add it to other tests in our fleet of vans of mobile smart eye clinics," said Dr. Salman Abdullah Al-Mutairi, executive director of Enayah Charitable Association and secretary general of the council of private association in the Saudi Arabia.

"Diabetes is the largest cause of vision loss in the world and accessibility to an eye test such as this is one of the most important factors contributing to early diagnosis and treatment. We applaud Dr. Salman's initiative to bring eye screening to remote communities with mobile clinics," said Yves-Stephane Couture, vice-president of sales for Diagnos.

"We salute this new innovative engagement from Enayah and their contribution to bring care to remote communities and to patients with reduced mobility. Technology is working towards bringing down barriers for all to have access to quality health care and we are proud to bring this initiative to Saudi Arabia. To that effect, CARA is now hosted locally at Saudi Telecom (STC) Cloud Services with the collaboration of Hajz Telecom," said Abdul-Aziz Rashid Al-Mugait, general manager of Kanhoor Medical.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire artificial intelligence (AI) platform. Flaire allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's AI-based image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.